A 17q12 allele is associated with altered NK cell subsets and function

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3315-3322

  Xia, Zongqi ^a,b,c   Liu, Qingquan ^c,d   Berger, Christoph T ^c,d   Keenan, Brendan T ^a,b,c   Kaliszewska, Anna ^a,b,c   Cheney, Patrick C ^c,d   Srivastava, Gyan P ^a,b,c   Castillo, Irene Wood ^a,b,c   De Jager, Philip L ^a,b,c   Alter, Galit ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2A;

ADULT; ALLELE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL SPECIFICITY; CHROMOSOME 17Q; COHORT ANALYSIS; CYTOTOXIC LYMPHOCYTE; DEGRANULATION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TBX21 GENE;

ADULT; ALLELES; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD56; CELL SEPARATION; CHEMOKINE CCL4; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOPOIESIS; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION, GENETIC;

EID: 84859414433     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102775     Document Type: Article

References (36)

1. Berger, C. T., and G. Alter. 2011. Natural killer cells in spontaneous control of HIV infection. Curr. Opin. HIV AIDS 6: 208-213.
2. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49. (Pubitemid 33741974)
3. Kim, S., J. B. Sunwoo, L. Yang, T. Choi, Y. J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 105: 3053-3058. (Pubitemid 351723666)
4. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
5. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640. (Pubitemid 33043908)
6. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
7. Ferreira, M. A., M. Mangino, C. J. Brumme, Z. Z. Zhao, S. E. Medland, M. J. Wright, D. R. Nyholt, S. Gordon, M. Campbell, B. P. McEvoy, et al and International HIV Controllers Study. 2010. Quantitative trait loci for CD4: CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am. J. Hum. Genet. 86: 88-92.
8. Hall, M. A., K. R. Ahmadi, P. Norman, H. Snieder, A. J. MacGregor, R. W. Vaughan, T. D. Spector, and J. S. Lanchbury. 2000. Genetic influence on peripheral blood T lymphocyte levels. Genes Immun. 1: 423-427.
9. Grieco, F. A., F. Vendrame, I. Spagnuolo, and F. Dotta. 2011. Innate immunity and the pathogenesis of type 1 diabetes. Semin. Immunopathol. 33: 57-66.
10. Rodacki, M., A. Milech, and J. E. de Oliveira. 2006. NK cells and type 1 diabetes. Clin. Dev. Immunol. 13: 101-107. (Pubitemid 44950029)
11. Gandhi, R., A. Laroni, and H. L. Weiner. 2010. Role of the innate immune system in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 221: 7-14.
12. Schleinitz, N., F. Vély, J. R. Harlé, and E. Vivier. 2010. Natural killer cells in human autoimmune diseases. Immunology 131: 451-458.
13. De Jager, P. L., E. Rossin, S. Pyne, P. Tamayo, L. Ottoboni, V. Viglietta, M. Weiner, D. Soler, E. Izmailova, L. Faron-Yowe, et al. 2008. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain 131: 1701-1711. (Pubitemid 351957464)
14. bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103: 5941-5946.
15. bright NK cells. J. Immunol. 185: 1311-1320.
16. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. (Pubitemid 40563170)
17. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. de Bakker, M. J. Daly, and P. C. Sham. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81: 559-575. (Pubitemid 47330214)
18. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
19. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20: 477-494. (Pubitemid 38482125)
20. Béziat, V., B. Descours, C. Parizot, P. Debré, and V. Vieillard. 2010. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5: e11966.
21. Harrison, R. J., A. Ettorre, A. M. Little, and S. I. Khakoo. 2010. Association of NKG2A with treatment for chronic hepatitis C virus infection. Clin. Exp. Immunol. 161: 306-314.
22. Tjwa, E. T., G. W. van Oord, J. P. Hegmans, H. L. Janssen, and A. M. Woltman. 2011. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 54: 209-218.
23. Zhang, R., J. Xu, K. Hong, L. Yuan, H. Peng, H. Tang, P. Ma, Y. Zhang, H. Xing, Y. Ruan, and Y. Shao. 2007. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. AIDS 21(Suppl 8): S9-S17.
24. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799. (Pubitemid 28099678)
25. - cells: a possible mechanism of tolerance during NK cell development. J. Immunol. 162: 6976-6980.
26. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342. (Pubitemid 44224147)
27. Peng, S. L. 2006. The T-box transcription factor T-bet in immunity and autoimmunity. Cell. Mol. Immunol. 3: 87-95.
28. Nath, N., R. Prasad, S. Giri, A. K. Singh, and I. Singh. 2006. T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology 118: 384-391.
29. Miller, S. A., and A. S. Weinmann. 2010. Molecular mechanisms by which T-bet regulates T-helper cell commitment. Immunol. Rev. 238: 233-246.
30. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
31. H1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295: 338-342.
32. Jenne, C. N., A. Enders, R. Rivera, S. R. Watson, A. J. Bankovich, J. P. Pereira, Y. Xu, C. M. Roots, J. N. Beilke, A. Banerjee, et al. 2009. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206: 2469-2481.
33. Kent, W. J., C. W. Sugnet, T. S. Furey, K. M. Roskin, T. H. Pringle, A. M. Zahler, and D. Haussler. 2002. The human genome browser at UCSC. Genome Res. 12: 996-1006. (Pubitemid 34662293)
34. Schwarz, D. A., C. D. Katayama, and S. M. Hedrick. 1998. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity 9: 657-668. (Pubitemid 28557594)
35. Katsoulidis, E., N. Carayol, J. Woodard, I. Konieczna, B. Majchrzak-Kita, A. Jordan, A. Sassano, E. A. Eklund, E. N. Fish, and L. C. Platanias. 2009. Role of Schlafen 2 (SLFN2) in the generation of interferon a-induced growth inhibitory responses. J. Biol. Chem. 284: 25051-25064.
36. Katsoulidis, E., E.Mavrommatis, J.Woodard,M.A. Shields,A. Sassano,N.Carayol, K. T. Sawicki, H. G. Munshi, and L. C. Platanias. 2010. Role of interferon alpha (IFNα)-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells. J. Biol. Chem. 285: 40333-40341.